EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways



RANKL-stimulated TNFalpha production in osteoclast precursor cells promotes osteoclastogenesis by modulating RANK signaling pathways



Biochemical and Biophysical Research Communications 357(4): 945-950



Although TNF alpha is known to be an important factor for bone resorption, particularly in inflammatory bone diseases, the relevance between RANKL and TNF alpha in osteoclastogenesis remains unclear. In this study we examined the mechanism of TNF alpha induced osteoclastogenesis and its downstream signaling. We show that osteoclastogenesis is suppressed by anti-TNF alpha- and anti-TNF receptor type I (TNFRI)-antibodies and in TNF alpha- and TNFRI-deficient mice using in vitro culture systems: (1) co-culture of mouse spleen derived osteoclast precursor cells (pOCs) with osteoblasts, (2) pure pOC culture and (3) RAW264.7 cells in presence of RANKL. Furthermore, TNF alpha production in pOCs was stimulated by RANKL. Endogenous TNF alpha in pOCs induced c-Fos and NFATc1. Expression rates of NFATc1 and c-Fos were significantly decreased in TNF alpha- and TNFRI-deficient pOCs during osteoclastogenesis. These results indicate that TNF alpha is induced by RANKL in pOCs and serves as an autocrine factor promoting osteoclastogenesis through c-Fos and NFATc1 activation.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333208

Download citation: RISBibTeXText

PMID: 17467668

DOI: 10.1016/j.bbrc.2007.04.058



Related references

A triterpene glycoside from black cohosh that inhibits osteoclastogenesis by modulating RANKL and TNFalpha signaling pathways. Chemistry & Biology 14(7): 860-869, 2007

Cyclosporines and FK506 inhibit osteoclastogenesis and osteoclast survival Role of down-regulation of RANK/RANKL signaling. Journal of Bone & Mineral Research 16(Suppl 1): S510, September, 2001

Selective β2-adrenoreceptor signaling regulates osteoclastogenesis via modulating RANKL production and neuropeptides expression in osteocytic MLO-Y4 cells. Journal of Cellular Biochemistry: -, 2018

Rifampin suppresses osteoclastogenesis and titanium particle-induced osteolysis via modulating RANKL signaling pathways. Biochemical and Biophysical Research Communications 484(1): 64-70, 2017

Rutaecarpine attenuates osteoclastogenesis by impairing M-CSF and RANKL-stimulated signaling pathways. Clinical and Experimental Pharmacology & Physiology: -, 2018

Tumor necrosis factor-a (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. The Journal of Biological Chemistry 276(1): 3-8, 2001

Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. Journal of Biological Chemistry 276(1): 563-568, 2000

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. Journal of Bone and Mineral Research 19(2): 207-213, 2004

18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways. Frontiers in Pharmacology 9: 647-647, 2018

Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways. Biochemical and Biophysical Research Communications 449(3): 344-350, 2014

Systemic TNFa promotes erosive bone resorption by increasing the number of CD11b+ osteoclast progenitors in the periphery which are dependent on RANK signaling for osteoclastogenesis. Journal of Bone & Mineral Research 17(Suppl 1): S130, September, 2002

AB0069Follistatin-like 1 Promotes Osteoclast Differentiation via RANKL-Mediated Activation of NF-B and MAPK Signaling Pathways. Annals of the Rheumatic Diseases 75(Suppl 2): 920.3-921, 2016

Osteoclast formation in osteoclast precursor cell line RAW2647 is not correlated to OPG, RANK or RANKL expression, but is influenced by culture conditions. Journal of Bone & Mineral Research 16(Suppl 1): S506, September, 2001

Aminothiazoles inhibit osteoclastogenesis and PGE2 production in LPS-stimulated co-cultures of periodontal ligament and RAW 264.7 cells, and RANKL-mediated osteoclastogenesis and bone resorption in PBMCs. Journal of Cellular and Molecular Medicine 23(2): 1152-1163, 2018

Siglec-15 regulates osteoclast differentiation by modulating RANKL-induced phosphatidylinositol 3-kinase/Akt and Erk pathways in association with signaling Adaptor DAP12. Journal of Bone and Mineral Research 28(12): 2463-2475, 2014